Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 268,522 shares at $45.19 ($12.1M) on 2024-08-29, disclosed to the SEC on 2024-08-30.
Scheduled sale ($12.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.41 | 16,386 | $728K | 6.0% |
| 2 | $44.41 | 16,386 | $728K | 6.0% |
| 3 | $44.94 | 61,467 | $2.8M | 22.8% |
| 4 | $44.94 | 61,467 | $2.8M | 22.8% |
| 5 | $45.19 | 45,640 | $2.1M | 17.1% |
| 6 | $45.19 | 45,640 |
| $2.1M |
| 17.1% |
| 7 | $45.81 | 10,768 | $493K | 4.1% |
| 8 | $45.81 | 10,768 | $493K | 4.1% |
| Total | $45.03 avg | 268,522 | $12.1M | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |